Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
13.20
-0.16 (-1.22%)
Feb 25, 2026, 2:47 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $21.28 million as of February 26, 2026. Its market cap has increased by 12.29% in one year.
Market Cap
21.28M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.20
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 21.28M, a decrease of -97.88%. That is a compound annual growth rate of -54.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 21.28M | -1.76% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | 1.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 39.00M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 29.68M |
| EOM Pharmaceuticals Holdings | 22.71M |
| Oncotelic Therapeutics | 20.09M |
| Provectus Biopharmaceuticals | 19.54M |
| Zeo ScientifiX | 18.47M |
| Zenith Capital | 15.97M |